I never imagined that providing standard, evidence-based medical care, and explaining that care clearly to patients, could put me at risk of federal prosecution.
Yet that is the position I find myself in today.
I am a board-certified family medicine physician and the founder of a small queer- and trans-owned clinic providing gender affirming care. Our clinic is now at the center of a Department of Justice appeal after we successfully quashed a federal subpoena seeking access to patient records. The DOJ has chosen to appeal that ruling, and oral arguments are approaching March 6.
This case is not just about my clinic. It is about precedent. And it should concern every physician, regardless of specialty.
At the heart of this case is a novel and deeply troubling legal theory: The federal government is attempting to regulate patient educational materials as if they were drug labeling, and to apply enforcement mechanisms traditionally reserved for pharmaceutical manufacturers to individual clinicians.
Historically, the Federal Food, Drug, and Cosmetic Act exists to regulate drugs and devices, specifically how they are manufactured, marketed, and labeled by companies. It was not designed to govern how physicians talk to patients, explain risks and benefits, or engage in shared decision-making. Yet that boundary is now being tested.
If patient education can be reclassified as drug labeling, then ordinary clinical conversations, written materials, and informed consent documents suddenly become potential federal liabilities. Physicians are no longer just caregivers; they become targets of regulatory enforcement for how they communicate medical information.
The implications of politicized medicine
That shift has enormous implications.
If upheld, this interpretation would allow the federal government to scrutinize and potentially prosecute physicians not for harming patients or deviating from the standard of care, but for providing care, and education, that the government finds objectionable. The scope of that power does not end with gender affirming care. It could be applied to reproductive health, contraception counseling, HIV prevention, addiction treatment, or any area of medicine that becomes politically contested.
This is how medicine becomes politicized without passing a single new law.
For our clinic, resisting this overreach has come at a steep cost. Fighting a federal subpoena is not a theoretical exercise. It requires endless meetings with attorneys, the preparation of declarations and timelines, and the diversion of time and resources away from patient care. It has meant lost work hours, lost wages, and the need to bring in additional legal and security consultants to protect our staff and our patients.
These burdens are not abstract. They show up in longer days, heavier caseloads, and the quiet recalibration required to keep going under sustained scrutiny. What has been most striking, though, is the resilience of our team.
The moral injury
For me personally, the toll has been profound. The stress of being targeted for doing my job has reshaped my life, determining where I live, how I work, and how much capacity I have left at the end of the day. There is a constant background hum of vigilance that never quite turns off. That kind of pressure is not accidental; it is a feature of enforcement strategies meant to deter care.
What makes this especially painful is the moral injury involved.
I did not provide this care casually. I provided it thoughtfully, guided by medical evidence, professional guidelines, and my ethical obligations as a physician. I spent years training to make careful clinical decisions and to communicate honestly with patients. To be investigated for meeting those obligations, to be treated as if patient education itself were suspect, creates a deep rupture between professional values and lived reality.
Physicians rely on trust: trust that informed consent matters, that clear communication protects patients, and that practicing within the standard of care offers some measure of safety. When those assumptions are undermined, the practice of medicine itself changes.
Many clinicians may assume this could never apply to them. That their specialty is too mainstream, their patient population too acceptable, their educational materials too ordinary to draw scrutiny. But once the line is crossed, once patient education is regulated as drug labeling and physicians are treated like manufacturers, there is no obvious stopping point.
A refusal to retreat
The chilling effect is real. You do not need widespread prosecutions to change behavior. The threat alone is enough to make clinicians pause, revise language, stop offering services, or leave fields altogether. Access erodes quietly, not because care is illegal, but because it becomes too risky to provide.
We chose not to retreat. We chose to challenge the subpoena and continue caring for patients throughout this process with the support of ACLU-WA. That decision has required resilience, sacrifice, and community support. It has also clarified what is at stake.
This appeal will help determine whether physicians retain the ability to educate patients freely and practice evidence-based medicine without fear of federal reprisal, or whether regulatory law can be repurposed to police clinical conversations.
That question extends far beyond my clinic.
I am sharing this not to invite sympathy, but to invite attention. The precedent being tested here will shape the future of patient education, physician autonomy, and trust in the exam room. Silence from the medical community in moments like this is not neutrality. It is permission.
The practice of medicine depends on our willingness to defend not just our patients, but the conditions that make ethical care possible in the first place.
Crystal Beal is a family physician.
